Home/EpiBiologics/Aaron Mishel

AM

Aaron Mishel

Chief Financial Officer

Therapeutic Areas

Oncology Immunology Autoimmune Disorders

EpiBiologics Pipeline

Drug	Indication	Phase
c-MET Degrading Bispecific Antibody	Oncology (likely various solid tumors)	Preclinical

Leadership Team at EpiBiologics

Ann Lee-Karlon, Ph.D.

Chief Executive Officer and President

Shyra Gardai, Ph.D.

Chief Scientific Officer

Eric Humke, M.D., Ph.D.

Chief Medical Officer

Jennifer Cygan, Ph.D.

Chief Business Officer

Jim Wells, Ph.D.

Scientific Founder

View full EpiBiologics profile